Dr. Cynthia Owusu, MD

Dr. Owusu practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Dr. Owusu's NPI, 1306878962, was assigned on July 6, 2006. Dr. Owusu holds Ohio license 35087453.

Dr. Owusu's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Dr. Owusu's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. The medical group on file is University Hospitals Medical Practices.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Owusu practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Owusu's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Owusu is licensed in Ohio.

CMS data shows 127 Medicare services from Dr. Owusu across 2 procedure codes in 2024, all of them office visits, for 62 Medicare patients. Medicare paid $10,724 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 62 Medicare patients who saw Dr. Owusu in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Owusu's median patient age at 70, with 91% women.

In 2024, Dr. Owusu wrote 686 Medicare Part D claims for 133 patients. 77% of them were for generic drugs. CMS names the drug for 602 of them, across 14 drugs with 11 or more claims each, at $1,749,474 in total drug cost. In 2023, CMS named 862 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Owusu for performance year 2024, reported as part of a group. Dr. Owusu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Owusu as offering telehealth.

Dmand AI links 62 papers to Dr. Owusu, published from 2011 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Ohio and Antineoplastic Agents. Dr. Owusu has published most often in J Geriatr Oncol. Dr. Owusu's most frequent co-authors are Ajeet Gajra, MD, Heidi D. Klepin, MD and Supriya Gupta Mohile, MD.

Dmand AI links Dr. Owusu to 6 clinical trials, 4 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Lobular.

CMS Open Payments shows 13 general payments to Dr. Owusu from 5 drug and device companies from 2017 to 2024. Travel and lodging make up the largest share, 91% of the total. Bioverativ Therapeutics Inc. paid the most, $3,152.